The Daily Overview on MSN

Eli Lilly closes in on a deal to buy biotech Ventyx

Eli Lilly is moving to deepen its bet on inflammatory disease, striking a deal to acquire biotech player Ventyx Biosciences ...

SPARC targets $10 million cost savings, consolidates R&D ops in Vadodara site

The company is consolidating its operations in Vadodara, with US headcount slashed by over 80 percent, labs reduced from four ...

Frontier Medicines Announces Publication in Nature Communications Highlighting a Novel Method that Enables Next-Generation Covalent Medicines

Notably, the paper also includes simulation studies outlining when dDRTC is most effective, positioning it as a practical ...